Neurofibromatosis – Basic Information

Go back

Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerves throughout the body, affecting the skin, nervous system, and sometimes other organs. While most tumors are not cancerous, this lifelong condition requires careful monitoring and can present different challenges at each stage of life.

Understanding Neurofibromatosis: A Global Perspective

Neurofibromatosis represents a significant genetic health challenge worldwide, affecting thousands of families across different continents. This group of conditions is more common than many people realize, with neurofibromatosis type 1 being the most frequently diagnosed form. Understanding how many people live with this condition helps us appreciate the need for awareness, research, and support systems.

Neurofibromatosis type 1, often called NF1, is the most common form of the condition, occurring in approximately one out of every 3,000 births worldwide. This makes it one of the more common genetic disorders, affecting roughly 1 in 2,500 people according to some estimates. NF1 accounts for about 96 percent of all neurofibromatosis cases, which means that when someone mentions neurofibromatosis, they are most likely referring to this particular type.[1][2][4]

The second most common type, now called NF2-related schwannomatosis (formerly known as neurofibromatosis type 2), is much rarer. This condition affects approximately one out of every 33,000 to 40,000 births worldwide, making up about 3 percent of all neurofibromatosis cases. The third type, called schwannomatosis, is the rarest form, accounting for only about 1 percent of cases, with an estimated occurrence of one in 40,000 births.[2][4]

These conditions do not discriminate based on gender or ethnicity. Both males and females are affected equally by neurofibromatosis, and the condition appears across all racial and ethnic groups around the world. The genetic nature of the condition means it can be passed down through families, though many cases occur without any family history.[5]

What Causes Neurofibromatosis

Neurofibromatosis is caused by changes in specific genes that normally help control cell growth. These genetic changes are not caused by anything a parent did or didn’t do during pregnancy, nor are they the result of environmental factors or lifestyle choices. They are simply changes that occur in the DNA, the instruction manual that tells our bodies how to grow and function.

For neurofibromatosis type 1, the condition results from a mutation in a gene called the NF1 gene. This gene is responsible for producing a protein called neurofibromin, which acts as a tumor suppressor. Think of neurofibromin as a brake pedal for cell growth. When the NF1 gene is mutated, the body cannot produce enough working neurofibromin protein. Without this brake pedal functioning properly, certain cells in the body grow and divide more than they should, leading to the formation of tumors.[1][4]

The NF1 gene mutation causes increased activity in a cellular pathway called the RAS signaling pathway. This pathway normally helps control cell growth and division. When neurofibromin is absent or not working correctly, the RAS pathway becomes overactive, which results in increased cell growth and proliferation. This is why people with NF1 develop various types of tumors throughout their lives.[12]

NF2-related schwannomatosis, the second type of neurofibromatosis, is caused by mutations in a different gene called the NF2 gene (also called neurofibromin 2 or merlin). This gene also functions as a tumor suppressor, though it works differently than the NF1 gene. When this gene is mutated, it leads to the development of different types of tumors than those seen in NF1.[4]

⚠️ Important
About half of people with NF1 inherit the genetic mutation from a parent who has the condition. However, in the other half of cases, the mutation occurs spontaneously during early development for unknown reasons. This means that a child can be born with NF1 even when neither parent has the condition. This spontaneous mutation is not caused by anything the parents did.

Schwannomatosis is not well understood compared to the other two types. Research suggests that approximately 85 percent of schwannomatosis cases occur spontaneously without any family history, while about 15 percent are inherited from a parent. Different genetic mutations can cause schwannomatosis, including mutations in genes called SMARCB1 and LZTR1.[4]

The inheritance pattern for NF1 and NF2 is called autosomal dominant. This means that if one parent has the condition, each of their children has a 50 percent chance of inheriting the genetic mutation and developing the condition. It only takes one copy of the mutated gene from one parent to cause the disorder. The other parent does not need to carry the mutation for a child to be affected.[4]

Who Is at Risk for Developing Neurofibromatosis

The primary risk factor for developing neurofibromatosis is having a biological parent with the condition. Because neurofibromatosis types 1 and 2 follow an autosomal dominant inheritance pattern, children of affected parents face a significant likelihood of inheriting the genetic mutation. Each child born to a parent with NF1 or NF2 has a 50 percent chance of inheriting the condition.[4]

However, family history is not always a risk factor. As mentioned earlier, about half of all NF1 cases and some cases of NF2 occur spontaneously without any family history. This means that any family can be affected, regardless of whether anyone in their family tree has ever had the condition. Scientists do not yet understand why these spontaneous mutations occur, which makes it impossible to predict who will develop a new spontaneous case.[2]

Unlike many other health conditions, neurofibromatosis does not have lifestyle-related risk factors. Your diet, exercise habits, exposure to chemicals, where you live, or your occupation do not increase or decrease your risk of developing neurofibromatosis. The condition is purely genetic, determined at conception or during very early development.[1]

Age and gender do not influence who develops neurofibromatosis. Both males and females are equally likely to inherit or develop the condition. Similarly, people of all ethnic backgrounds and races have the same risk of being affected. The condition appears with similar frequency across all populations worldwide.[5]

For families who already have one child with neurofibromatosis due to a spontaneous mutation, the risk of having another child with the condition is very low unless one of the parents also has the genetic mutation in some of their cells. Genetic counseling can help families understand their specific risks and make informed decisions about family planning.[8]

Recognizing the Symptoms of Neurofibromatosis

The symptoms of neurofibromatosis vary greatly from person to person, even within the same family. Some people experience mild symptoms that barely affect their daily lives, while others face more significant challenges. The type of neurofibromatosis, the location of tumors, and individual differences all influence how the condition manifests.

For neurofibromatosis type 1, the most recognizable symptom is the appearance of flat, light brown patches on the skin called café au lait spots. These spots look like someone has painted areas of skin with coffee mixed with milk, which is what “café au lait” means in French. While many people have one or two of these spots without having NF1, people with the condition typically have six or more. In children, these spots are usually at least half a centimeter in diameter, while in adults they grow to be larger than 1.5 centimeters. These spots are usually present at birth or appear during the first few years of life.[1][3]

Another distinctive skin feature of NF1 is freckling in unusual places. Rather than appearing on sun-exposed areas like the face, these freckles develop in areas that are typically covered by clothing, such as the armpits, groin area, and sometimes under the breasts. These freckles are smaller than café au lait spots and tend to appear in clusters. They typically develop by age 3 to 5 years.[1][3]

Tumors called neurofibromas are another hallmark of NF1. These are soft, pea-sized bumps that can appear on or just under the skin. Some neurofibromas are visible as small bumps on the skin’s surface (called cutaneous neurofibromas), while others grow beneath the skin (subcutaneous neurofibromas). Although some may develop in childhood, most appear during or after the teenage years and may become more numerous as a person ages. These tumors can sometimes be itchy or painful, especially if they press against nearby structures.[1][2]

A more complex type of tumor called a plexiform neurofibroma occurs in about 50 percent of people with NF1. Unlike the smaller neurofibromas, plexiform neurofibromas involve multiple nerves and can grow quite large. They may appear as swollen areas under the skin or cause internal problems depending on their location. These tumors can cause pain, numbness, weakness, or other symptoms if they press on nerves or organs. About 10 to 15 percent of plexiform neurofibromas can become cancerous over a person’s lifetime.[1]

People with NF1 may also develop small growths on the colored part of the eye called Lisch nodules. These are harmless bumps on the iris that do not affect vision and can only be seen during a specialized eye examination. They typically appear during the teenage years. Some people also develop tumors on the optic nerve, the nerve that connects the eye to the brain, which can affect vision.[1][3]

Bone problems are also common in NF1. Some children develop abnormal curvature of the spine, known as scoliosis, or bowing of the leg bones. Some may have a larger-than-average head size or shorter-than-average height. These skeletal changes can sometimes require medical intervention.[1][2]

Learning difficulties affect many children with NF1, although intelligence is usually in the normal range. Children may struggle with attention, reading, writing, or math. Some children may also have attention-deficit/hyperactivity disorder. These challenges can affect school performance and may require extra educational support.[1][2]

Headaches are more common in people with NF1 than in the general population. Other possible symptoms include high blood pressure, which can develop at any age, and in rare cases, seizures or other neurological symptoms.[6][8]

NF2-related schwannomatosis presents differently. The characteristic feature is the development of slow-growing tumors on the nerves responsible for hearing and balance, called vestibular schwannomas. These tumors typically affect both ears and can cause early-onset hearing loss, ringing in the ears (tinnitus), balance problems, and difficulty walking. People with this type may also develop cataracts at a young age, experience numbness or weakness in the arms or legs, and develop other types of nerve tumors.[2][5]

Schwannomatosis, the third type, often presents with chronic pain as the primary symptom. This pain results from nerve tumors pressing on surrounding tissues. People may also experience numbness, tingling, or weakness. Unlike NF2, schwannomatosis typically does not affect hearing.[2]

Can Neurofibromatosis Be Prevented

Currently, there is no known way to prevent neurofibromatosis. Because the condition is caused by genetic mutations that occur either spontaneously or are inherited, it cannot be prevented through lifestyle changes, dietary modifications, medications, or any other interventions. The genetic changes that cause neurofibromatosis happen at conception or during very early development, long before anyone could take preventive action.[1][6]

While the condition itself cannot be prevented, many of its complications can be managed or prevented through early detection and appropriate care. This is why regular monitoring is so important for people with neurofibromatosis. Annual checkups allow healthcare providers to detect potential problems early, when they are easier to treat and less likely to cause serious complications.[6][9]

For people with NF1, yearly eye examinations are crucial for detecting vision problems early. Children with NF1 should have their eyes checked every year, while adults should have examinations every two years. These regular eye checks can identify optic nerve tumors or other eye problems before they cause significant vision loss. Early detection means treatment can begin sooner, potentially preserving vision.[6][9]

Blood pressure monitoring is another important preventive measure. People with NF1 should have their blood pressure checked at least once a year because they have a higher risk of developing high blood pressure. High blood pressure can lead to serious complications if left untreated, but it can be effectively managed with medication and lifestyle changes when detected early.[6][9]

Regular physical examinations help monitor for new tumors or changes in existing ones. Healthcare providers will check the skin for new neurofibromas, examine the spine for signs of scoliosis, and assess overall growth and development in children. These checkups also provide an opportunity to discuss any new symptoms or concerns, such as pain, weakness, or numbness that might indicate a tumor is pressing on a nerve.[9]

For families with a history of neurofibromatosis, genetic counseling can be valuable. Genetic counselors can help families understand the inheritance patterns, assess the risk of passing the condition to future children, and discuss options for family planning. Prenatal genetic testing is available for families who want to know whether a developing baby has inherited the genetic mutation, though this testing is optional and a personal choice.[9]

While preventing complications is important, it is equally important to focus on maintaining overall health. This includes eating a balanced diet, staying physically active within any limitations imposed by the condition, getting adequate sleep, and managing stress. These general health measures won’t prevent neurofibromatosis or its specific complications, but they can help people with the condition maintain the best possible quality of life.[17]

For children with NF1 who have learning difficulties, early educational intervention can help prevent academic struggles from becoming overwhelming. Extra support at school, specialized teaching methods, or accommodations can help children with NF1 succeed academically and build confidence.[6]

Women with NF1 should begin regular breast cancer screening, such as mammograms, starting at age 40, as they have a higher risk of developing breast cancer. This earlier and more vigilant screening can help detect any problems at the earliest, most treatable stage.[6]

How Neurofibromatosis Affects the Body

Understanding how neurofibromatosis changes the way the body normally functions helps explain why the condition causes such a wide variety of symptoms. The changes occur at the cellular level, affecting how cells grow and divide throughout the body, particularly cells in the nervous system and skin.

In a healthy body, cells grow, divide, and die in a carefully controlled manner. This process is regulated by many different proteins, including tumor suppressor proteins. These proteins act like quality control managers, ensuring that cells only divide when they should and stopping the process when enough new cells have been created. The neurofibromin protein, which is affected in NF1, is one of these important tumor suppressors.[4]

When someone has NF1, their body cannot produce enough working neurofibromin protein. This protein normally helps control a cellular pathway called the RAS pathway, which regulates cell growth and division. Without enough neurofibromin acting as a brake, the RAS pathway becomes overactive. This means cells receive constant signals to grow and divide, even when they shouldn’t. The result is the formation of tumors, which are simply masses of cells that have grown more than they should.[12]

The tumors that develop in neurofibromatosis arise from cells that support the nervous system, particularly cells that form protective coverings around nerves. These supporting cells are called Schwann cells, and they normally wrap around nerves like insulation around electrical wires. In neurofibromatosis, these cells grow excessively, forming tumors called neurofibromas or schwannomas depending on their exact cell type and characteristics.[5]

In NF1, neurofibromas can develop anywhere in the body where nerves are present, which means virtually anywhere. When these tumors grow on nerves close to the skin, they appear as visible or palpable bumps. When they grow on nerves deeper in the body, they may press on organs, blood vessels, or other structures, potentially causing pain or interfering with normal function. For example, a neurofibroma growing near the spinal cord might press on the cord or nerve roots, causing back pain, numbness, or weakness in the limbs.[1]

Plexiform neurofibromas, the more complex tumors seen in NF1, develop from multiple nerves simultaneously. They can grow quite large and infiltrate surrounding tissues, making them difficult to remove surgically. These tumors may affect blood vessels, bones, and other structures as they grow. When plexiform neurofibromas involve nerves that control important functions, they can cause significant problems. For instance, a plexiform neurofibroma near the spine could affect bladder or bowel control.[1]

The absence of neurofibromin also affects other body systems beyond tumor formation. The protein plays roles in bone development, which is why some people with NF1 develop bone abnormalities such as bowing of the legs, spine curvature, or thin bones that are prone to fractures. The mechanisms behind these bone changes are still being researched, but they appear to involve disrupted communication between different cell types during bone formation and maintenance.[8]

The cardiovascular system can also be affected. Some people with NF1 develop blood vessel abnormalities, including narrowing of blood vessels or abnormal connections between arteries and veins. The renal arteries, which supply blood to the kidneys, can become narrowed, leading to high blood pressure. Understanding these vascular changes helps explain why blood pressure monitoring is so important for people with NF1.[13]

In the eyes, neurofibromin deficiency can lead to tumors growing on the optic nerve, the nerve that carries visual information from the eye to the brain. These tumors, called optic gliomas, can interfere with vision by pressing on the nerve or disrupting its normal function. The Lisch nodules that appear on the iris are accumulations of cells containing the pigment melanin, though they don’t affect vision because they don’t interfere with the lens or retina.[16]

The learning difficulties seen in many people with NF1 result from subtle changes in how the brain develops and functions. Neurofibromin appears to play a role in learning and memory, possibly through its effects on brain cell communication. When the protein is deficient, it can affect attention, information processing, and specific learning skills, though overall intelligence is usually normal.[1]

In NF2-related schwannomatosis, the absence of the merlin protein leads primarily to schwannomas, tumors of Schwann cells. The bilateral vestibular schwannomas characteristic of this type develop because Schwann cells in the hearing and balance nerves grow excessively. As these tumors grow, they compress the nerves, interfering with the transmission of signals related to hearing and balance. This compression explains the progressive hearing loss and balance problems that people with this type experience.[2]

⚠️ Important
While most tumors in neurofibromatosis remain benign throughout a person’s life, there is a small but significant risk that some tumors can become cancerous. This transformation happens in about 3 to 5 percent of all neurofibromatosis cases. The risk is higher for certain types of tumors, particularly plexiform neurofibromas, which have about a 10 percent chance of becoming malignant over a person’s lifetime. This is why monitoring for changes in existing tumors is so important.

The physical and functional changes caused by neurofibromatosis can also have psychological and social effects. Visible tumors or other physical differences may affect self-esteem and social interactions. Chronic pain from tumors pressing on nerves can impact quality of life and mental health. These secondary effects on well-being are part of the condition’s impact on the body as a whole, highlighting the importance of comprehensive care that addresses not just physical symptoms but emotional and social needs as well.[17]

Ongoing Clinical Trials on Neurofibromatosis

  • Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Trametinib for Patients with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibromas

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Selumetinib for Children Aged 1 to 6 with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain
  • Study on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain

References

https://www.ninds.nih.gov/health-information/disorders/neurofibromatosis

https://my.clevelandclinic.org/health/diseases/neurofibromatosis

https://www.mayoclinic.org/diseases-conditions/neurofibromatosis-type-1/symptoms-causes/syc-20350490

https://www.aans.org/patients/conditions-treatments/neurofibromatosis/

https://en.wikipedia.org/wiki/Neurofibromatosis

https://www.nhs.uk/conditions/neurofibromatosis-type-1/

https://www.ncbi.nlm.nih.gov/books/NBK459329/

https://www.rch.org.au/kidsinfo/fact_sheets/Neurofibromatosis/

https://www.mayoclinic.org/diseases-conditions/neurofibromatosis-type-1/diagnosis-treatment/drc-20350495

https://my.clevelandclinic.org/health/diseases/neurofibromatosis

https://www.mdanderson.org/cancer-types/neurofibromatosis/neurofibromatosis-treatment.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC7975824/

https://emedicine.medscape.com/article/1177266-treatment

https://www.healthline.com/health/nf1-pn-self-care

https://drpanossian.com/blog/managing-neurofibromatosis-type-3/

https://www.henryford.com/Blog/2024/04/Living-With-Neurofibromatosis

https://unifyrare.com/en/nf1/living-with-nf1

https://my.clevelandclinic.org/health/diseases/14422-neurofibromatosis-type-1-nf1

https://www.mayoclinic.org/diseases-conditions/neurofibromatosis-type-1/diagnosis-treatment/drc-20350495

FAQ

If I have neurofibromatosis, will my children definitely have it too?

Not necessarily. If you have NF1 or NF2, each of your children has a 50 percent chance of inheriting the genetic mutation and developing the condition. This means it’s also possible that your child will not inherit the mutation. Genetic counseling can help you understand your specific situation and options for family planning.

Can café au lait spots appear in people without neurofibromatosis?

Yes, many people have one or two café au lait spots without having neurofibromatosis. However, having six or more of these spots strongly suggests NF1. The spots can also appear in other conditions, which is why a doctor must evaluate them along with other symptoms to make an accurate diagnosis.

Do neurofibromas continue to appear throughout life?

Yes, in NF1, new neurofibromas can appear throughout a person’s life. While some may develop during childhood, most appear during or after the teenage years. The number of neurofibromas often increases with age, and certain life events like puberty or pregnancy may trigger more tumor growth.

Is there any cure for neurofibromatosis?

Currently, there is no cure for neurofibromatosis. The condition is genetic and affects how cells throughout the body function. However, many symptoms and complications can be managed with monitoring, medications, and surgery when needed. Research is ongoing to develop new treatments that target the underlying genetic causes.

What is the life expectancy for someone with neurofibromatosis?

Most people with NF1 have a normal or near-normal life expectancy, especially with proper monitoring and treatment of complications. The condition affects everyone differently, with many people experiencing only mild symptoms. NF2-related schwannomatosis can be more serious and may affect life expectancy, but outcomes vary greatly depending on tumor locations and treatment responses.

🎯 Key takeaways

  • Neurofibromatosis affects about 1 in 3,000 people worldwide, making it more common than many realize, yet each person experiences the condition differently.
  • About half of all NF1 cases occur spontaneously without any family history, meaning the genetic mutation happens randomly rather than being inherited.
  • Having six or more café au lait spots and unusual freckling in the armpits or groin are often the earliest visible signs of NF1, typically appearing before age five.
  • While most tumors in neurofibromatosis remain benign, about 10 to 15 percent of plexiform neurofibromas can become cancerous over a person’s lifetime, highlighting the importance of monitoring.
  • Regular checkups that include eye examinations, blood pressure monitoring, and skin checks can help detect complications early when they are most treatable.
  • Many people with NF1 have learning difficulties or attention problems, but intelligence is usually normal, and children often benefit from educational support and accommodations.
  • The three types of neurofibromatosis are distinct conditions caused by different genetic mutations, with NF1 being by far the most common at 96 percent of cases.
  • New targeted therapies are being developed that can shrink certain types of tumors, offering hope for improved treatment options beyond surgery and monitoring.